Hillevax Inc
$1.69
(as of Apr 17, 4:00 PM EST)
Stock Market Guides is not a financial advisor. Our content is strictly educational and should not be considered financial advice.
Ticker Information for Hillevax Inc
Stock Price
$1.69
Ticker Symbol
HLVX
Exchange
NASDAQ
Industry Information for Hillevax Inc
Sector
Healthcare
Industry
Biotechnology
Company Description for Hillevax Inc
HilleVax, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company develops HIL-214, a virus-like particle-based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis caused by norovirus infection. It has a license agreement with Takeda for the commercialization of any pharmaceutical products with HIL-214 compounds. The company was formerly known as MokshaCo, Inc. and changed its name to HilleVax, Inc. in February 2021. HilleVax, Inc. was founded in 2019 and is headquartered in Boston, Massachusetts.
Fundamentals for Hillevax Inc
Market Capitalization
$84,738,464
EBITDA
$-105,083,000
Dividends per Share
P/E Ratio
Forward P/E Ratio
0
Earnings per Share
$-3
Earnings per Share Estimate Next Year
Profit Margin
Shares Outstanding
50,141,100
Percent Owned by Insiders
16.99%
Percent Owned by Institutions
72.19%
52-Week High
52-Week Low
Technical Indicators for Hillevax Inc
Analyst Ratings for Hillevax Inc
Strong Buy
0
Buy
0
Hold
5
Sell
0
Strong Sell
0
News About Hillevax Inc
Mar 28, 2025, 5:00 PM EST
$171.4 million of cash, cash equivalents and marketable securities as of December 31, 2024
See more.
Apr 14, 2024, 12:52 PM EST
In this article, we will take a detailed look at the 10 Buy-Rated Stocks with Latest Insider Purchases. See more.
Nov 9, 2023, 4:05 PM EST
BOSTON, Nov. See more.
Nov 1, 2023, 4:48 PM EST
BOSTON, Nov. See more.